Anticoagulant Micrurus venoms: targets and neutralization

Full metadata record
DC FieldValueLanguage
dc.contributorLab. Coleções Zoológicaspt_BR
dc.contributor.authorDashevsky, Danielpt_BR
dc.contributor.authorBenard-Valle, Melisapt_BR
dc.contributor.authorNeri-Castro, Edgarpt_BR
dc.contributor.authorYoungman, Nicholas J.pt_BR
dc.contributor.authorZdenek, Christina N.pt_BR
dc.contributor.authorAlagón, Alejandropt_BR
dc.contributor.authorPortes Junior, José Antoniopt_BR
dc.contributor.authorFrank, Nathanielpt_BR
dc.contributor.authorFry, Bryan G.pt_BR
dc.identifier.citationDashevsky D, Benard-Valle M, Neri-Castro E, Youngman NJ., Zdenek CN., Alagón A, et al. Anticoagulant Micrurus venoms: targets and neutralization. Toxicol. Lett.. 2021 Feb;337:91-97. doi:10.1016/j.toxlet.2020.11.010.pt_BR
dc.description.abstractSnakebite is a neglected tropical disease with a massive global burden of injury and death. The best current treatments, antivenoms, are plagued by a number of logistical issues that limit supply and access in remote or poor regions. We explore the anticoagulant properties of venoms from the genus Micrurus (coral snakes), which have been largely unstudied, as well as the effectiveness of antivenom and a small-molecule phospholipase inhibitor—varespladib—at counteracting these effects. Our in vitro results suggest that these venoms likely interfere with the formation or function of the prothrombinase complex. We find that the anticoagulant potency varies widely across the genus and is especially pronounced in M. laticollaris. This variation does not appear to correspond to previously described patterns regarding the relative expression of the three-finger toxin and phospholipase A2 (PLA2) toxin families within the venoms of this genus. The coral snake antivenom Coralmyn, is largely unable to ameliorate these effects except for M. ibiboboca. Varespladib on the other hand completely abolished the anticoagulant activity of every venom. This is consistent with the growing body of results showing that varespladib may be an effective treatment for a wide range of toxicity caused by PLA2 toxins from many different snake species. Varespladib is a particularly attractive candidate to help alleviate the burden of snakebite because it is an approved drug that possesses several logistical advantages over antivenom including temperature stability and oral availability.pt_BR
dc.description.sponsorship(FAPESP) Fundação de Amparo à Pesquisa do Estado de São Paulopt_BR
dc.relation.ispartofToxicology Letterspt_BR
dc.rightsRestricted accesspt_BR
dc.titleAnticoagulant Micrurus venoms: targets and neutralizationpt_BR
dc.contributor.external(UQ) University of Queenslandpt_BR
dc.contributor.external(ANIC) Australian National Insect Collectionpt_BR
dc.contributor.external(UNAM) Universidad Nacional Autónoma de Méxicopt_BR
dc.contributor.externalMToxins Venom Labpt_BR
dc.subject.keywordcoral snakept_BR
dc.subject.keywordelapid coagulotoxicitypt_BR
dc.subject.keywordsnakebite treatmentpt_BR
dc.subject.keywordprothrombinase inhibitionpt_BR
dc.relation.ispartofabbreviatedToxicol Lettpt_BR
dc.identifier.citationabntv. 337, p. 91-97, fev. 2021pt_BR
dc.identifier.citationvancouver2021 Feb;337:91-97pt_BR
dc.contributor.butantanPortes Junior, José Antonio|:Aluno|:Lab. Coleções Zoológicaspt_BR
dc.sponsorship.butantanFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)¦¦2018/25749-8pt_BR
dc.sponsorship.butantanAustralian Research Council (ARC)¦¦DP190100304pt_BR
item.fulltextCom Texto completo-
Appears in Collections:Artigos

Files in This Item:

Existing users please Login
Size: 942.67 kB
Format: Adobe PDF
Embargoed until January 1, 2999    Request a copy
Show simple item record

The access to the publications deposited in this repository respects the licenses from journals and publishers.